Abstract:Human immunodeficiency virus type 1 (HIV-1) continues to pose a significant global health challenge despite advances in combined antiretroviral therapy (cART), which has transformed HIV-1 infection from a fatal disease to a manageable chronic condition. However, cART is not curative, and its long-term use is associated with challenges such as pill burden, drug toxicities, and the emergence of drug-resistant viral strains. The persistence of active viral reservoirs necessitates lifelong treatment, highlighting the need for alternative therapeutic strategies capable of achieving HIV-1 remission or cure. Stem cell therapy has emerged as a promising approach to address these challenges by targeting latent viral reservoirs, restoring host immune function, and potentially achieving sustained viral suppression in the absence of cART. This review critically evaluates current scientific literature on stem cell therapies for HIV-1, focusing on three major approaches: 1) hematopoietic stem cell transplantation (HSCT), 2) gene therapy, and 3) cell-based immunotherapies. Each approach is examined in terms of its underlying mechanisms, clinical feasibility, recent advancements, and associated challenges. Furthermore, future research directions are discussed, emphasizing the optimization of the current treatment protocols, enhancement of safety and efficacy, and the importance of large-scale clinical trials with different cohorts (different HIV clades, different genders of participants, and pediatric HIV) to evaluate long-term outcomes that include effective and scalable HIV cure challenges. Collaborative efforts across multidisciplinary fields are needed to overcome existing barriers so to realize the full therapeutic potential of stem cell-based approaches for developing an effective and scalable remission or cure strategies.

The discovery and development of RNA-based therapies for treatment of HIV-1 infection

RNA interference and its therapeutic potential against HIV infection

Antiviral Stratagems against HIV-1 Using RNA Interference (RNAi) Technology

Lentiviral Delivery of RNAi Effectors Against HIV-1

Current Advances in RNA Therapeutics for Human Diseases

Innovative developments and emerging technologies in RNA therapeutics

Update on Recent Developments in Small Molecular HIV-1 RNase H Inhibitors (2013-2016): Opportunities and Challenges

Recent Advances and Prospects in RNA Drug Development

CRISPR therapy towards an HIV cure

RNAi-inducing lentiviral vectors for anti-HIV-1 gene therapy

Gene therapy for HIV infection

Small-molecule Inhibitors of HIV-1 Reverse Transcriptase-Associated Ribonuclease H Function: Challenges and Recent Developments

RNA-based Therapeutics: an Overview and Prospectus

Advancing towards HIV-1 remission: Insights and innovations in stem cell therapies

Antiviral RNAi therapy: emerging approaches for hitting a moving target

CCR5-targeted hematopoietic stem cell gene approaches for HIV disease: current progress and future prospects

Gene Therapy Strategies for the Treatment of HIV/AIDS

Current Medicinal Chemistry Strategies in the Discovery of Novel HIV-1 Ribonuclease H Inhibitors

Recent advances in the research of HIV-1 RNase H inhibitors.

Current state-of-the-art in preclinical and clinical development of novel non-nucleoside HIV-1 reverse transcriptase inhibitors

Treatment strategies for HIV infection with emphasis on role of CRISPR/Cas9 gene: Success so far and road ahead